PhRMA Wades Into FDA Patient-Focused Data Collection: Website Systems for Crowd-Sourced Info

Trade association partners with Genetic Alliance to provide input into FDA drug development initiative. That may be an effective intervention by PhRMA as it experiments with new ways to shape regulatory policy beyond traditional advocacy efforts.

More from Approval Standards

More from Pathways & Standards